SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-163092
Filing Date
2023-06-08
Accepted
2023-06-08 09:16:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d497652dposam.htm POS AM 21042
  Complete submission text file 0001193125-23-163092.txt   22037
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255201 | Film No.: 231000837
SIC: 2834 Pharmaceutical Preparations